We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA to Collect Adverse Event Data Despite UK Recall of Metal Hip Implants
U.S. FDA to Collect Adverse Event Data Despite UK Recall of Metal Hip Implants
March 9, 2011
Quality problems with metal-on-metal (MoM) hip replacement systems, like Johnson & Johnson (J&J)’s ASR devices, may not be as widespread as UK data indicates, the U.S. Food and Drug Administration (FDA) says.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor